Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to $113.9 million.

  • OptimizeRx's Other Non-Current Assets rose 3135911.6% to $113.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.9 million, marking a year-over-year increase of 3135911.6%. This contributed to the annual value of $117.0 million for FY2024, which is 919.13% down from last year.
  • OptimizeRx's Other Non-Current Assets amounted to $113.9 million in Q3 2025, which was up 3135911.6% from $115.1 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Other Non-Current Assets registered a high of $128.9 million during Q4 2023, and its lowest value of $362000.0 during Q3 2024.
  • In the last 5 years, OptimizeRx's Other Non-Current Assets had a median value of $36.1 million in 2023 and averaged $55.2 million.
  • As far as peak fluctuations go, OptimizeRx's Other Non-Current Assets plummeted by 9900.52% in 2024, and later surged by 3135911.6% in 2025.
  • Over the past 5 years, OptimizeRx's Other Non-Current Assets (Quarter) stood at $25.7 million in 2021, then soared by 39.68% to $35.9 million in 2022, then surged by 258.67% to $128.9 million in 2023, then decreased by 9.19% to $117.0 million in 2024, then decreased by 2.7% to $113.9 million in 2025.
  • Its Other Non-Current Assets was $113.9 million in Q3 2025, compared to $115.1 million in Q2 2025 and $115.9 million in Q1 2025.